A multicenter, retrospective archive study of radiological and clinical features of ALK-positive non-small cell lung cancer patients and crizotinib efficacy.

Medicine (Baltimore) · 2024 · PMC11124701 · PMID 38787994

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

However, these results might imply that gender and smoking may be significant factors to be considered in the clinical management of ALK+ NSCLC.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.